Chris Cheng

Committees: Nominating & Governance; term expiration: September 2024 (first)

Dr. Christopher Cheng splits his time between aerospace government contracting, the medical device industry, and academic research. Chris runs Global Science & Technology (gst.com), a contractor to NOAA, NASA, DoD, and USDA focusing on satellite remote sensing for weather and climate change monitoring. He also runs a consulting practice within GST dedicated to helping medical device companies holistically evaluate and improve durability and biomechanical compatibility of medical implants.

Chris is an Adjunct Professor in the Division of Vascular Surgery at Stanford, Director of the Vascular Intervention Biomechanics & Engineering lab (vibelab.stanford.edu), and President of Cardiovascular Implant Durability (cvidconference.org), a 501(c)(3) that helps the medical device industry develop more durable medical devices. He is considered the preeminent expert in vascular motion, having over 100 publications and edited Handbook of Vascular Motion (PROSE Book Award Nominee), the first and only book dedicated to how blood vessels move. Previously, Chris was co-founder and CEO of Kōli, Inc., an early-stage medical device company developing a catheter-based solution for gallstone disease. He studied BME and EE at Duke University, and earned his Master’s and Ph.D. in Biomechanics at Stanford University. Chris currently serves as a board member of the Duke University Pratt School of Engineering and participated in ALF Class XXXIX.